Fig. 4.
Adherence to DMAb treatment remained higher than that for BP treatment (Kaplan–Meier method). BP bisphosphonate, DMAb denosumab, PO patients with postmenopausal osteoporosis, RA osteoporosis patients with rheumatoid arthritis, RA + GC osteoporosis patients with rheumatoid arthritis taking glucocorticoids